Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

HCA Healthcare (HCA) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareHCA

Closing price · Nov 19, 2026 $461.58 -3.1% on the day · -3.4% over 12 months 52-week range $359.93 – $542.23
Get HCA alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling8last 12 months
Reported sales$47.5M0 of 23 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Jan 22, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Erica Rossitto, Svp & Chief Nurse Executive sold 3,500 shares at $505.81 ($1.8M).

Trade date
Nov 10, 2026
Disclosed to the SEC
Nov 10, 2026
Type
Sale (code S)

Read the original SEC filing ↗All HCA insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

HCA insider transactions (Form 4)

Open-market purchases and sales. 76 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 10SEC Erica RossittoSvp & Chief Nurse Executive Sell 3,50013,426 held (−21%) $505.81 $1.8M -8.7% —
Nov 6SEC Jon M. FosterCOO Sell 10,000 $514.07 $5.1M -10.2% —
Nov 6SEC Jon M. FosterCOO Sell 7,59517,786 held (−30%) $494.91 $3.8M -6.7% —
Nov 6SEC Jon M. FosterCOO Sell 6,30211,484 held (−35%) $493.58 $3.1M -6.5% —
Nov 6SEC Jon M. FosterCOO Sell 2,69225,381 held (−10%) $495.85 $1.3M -6.9% —
Nov 6SEC Jon M. FosterCOO Sell 1,68429,139 held (−5%) $498.00 $839K -7.3% —
Nov 6SEC Jon M. FosterCOO Sell 1,48410,000 held (−13%) $491.98 $730K -6.2% —
Nov 6SEC Michael J. SchlosserEvp And Chief Clinical Officer Sell 1,2001,443 held (−45%) $494.65 $594K -6.7% —
Nov 6SEC Jon M. FosterCOO Sell 1,06628,073 held (−4%) $496.92 $530K -7.1% —
Nov 6SEC Jon M. FosterCOO Sell 89030,823 held (−3%) $498.97 $444K -7.5% —
Feb 18SEC Michael R. McAleveyGeneral Counsel Sell 1,6948,853 held (−16%) $533.37 $904K -13.5% —
Feb 12SEC Jennifer BerresSvp & Chief Human Res. Officer Sell 4,01011,993 held (−25%) $526.16 $2.1M -12.3% —
Feb 12SEC Christopher F. WyattSvp & Controller Sell 4,00044,379 held (−8%) $505.00 $2.0M -8.6% —
Feb 12SEC Jennifer BerresSvp & Chief Human Res. Officer Sell 4,01016,003 held (−20%) $503.00 $2.0M -8.2% —
Feb 5SEC Samuel N. HazenCEO Sell 14,71660,437 held (−20%) $502.95 $7.4M -8.2% —
Feb 5SEC Samuel N. HazenCEO Sell 7,39548,040 held (−13%) $500.69 $3.7M -7.8% —
Feb 5SEC Samuel N. HazenCEO Sell 6,18941,851 held (−13%) $500.02 $3.1M -7.7% —
Feb 5SEC Samuel N. HazenCEO Sell 5,16236,689 held (−12%) $498.80 $2.6M -7.5% —
Feb 5SEC Samuel N. HazenCEO Sell 5,00255,435 held (−8%) $502.15 $2.5M -8.1% —
Feb 5SEC Samuel N. HazenCEO Sell 4,29332,396 held (−12%) $498.12 $2.1M -7.3% —
Feb 5SEC Michael S. CuffeEvp And Chief Clinical Officer Sell 1,50030,003 held (−5%) $498.09 $747K -7.3% —
Feb 5SEC Samuel N. HazenCEO Sell 12032,276 held (−0%) $497.18 $60K -7.2% —
Nov 5SEC Michael R. McAleveyGeneral Counsel Sell 3,8923,487 held (−53%) $473.79 $1.8M -2.6% —
Historical context

Similar past setups: not applicable. HCA has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with HCA in the Research Lab

HCA has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

HCA closeInsider buyInsider sale
300400500600DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-01-27EEarnings release filed 2026-04-24EEarnings release filed 2026-07-14EEarnings release filed 2026-07-24EEarnings release filed 2026-10-27Sold $903,537 on 2026-02-18 · Michael R. McAleveySold $1,770,335 on 2026-11-10 · Erica RossittoSold $5,734,281 on 2026-11-04 · Jon M. Foster, Michael J. SchlosserSold $6,146,950 on 2026-02-11 · Christopher F. Wyatt, Jennifer BerresSold $10,746,784 on 2026-11-06 · Jon M. FosterSold $22,230,410 on 2026-02-03 · Michael S. Cuffe, Samuel N. Hazen
Bought, 12 months$0
Sold, 12 months$47.5M
Insiders buying0
Insiders selling8

HCA Healthcare insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $47.5M of HCA stock on the open market; P/E 16.1 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

HCA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1.8M sold (1 trades)Q4 2025Q1 2026: $29.3M sold (12 trades)Q1 2026Q2 2026Q3 2026Q4 2026: $18.3M sold (10 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$18.3M10
Q3 2026—0—0
Q2 2026—0—0
Q1 2026—0$29.3M12
Q4 2025—0$1.8M1

Valuation, profit and volume

P/E (trailing)16.1Sector median 25.0
Volume vs. 50-day0.8×Last 5 sessions

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 HCA Healthcare insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $47.5M. 0 of 23 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

HCA earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 27, 2026 +3.1% None -0.4%S&P +0.9% pending
Jul 24, 2026 -8.3% None +3.5%S&P +0.1% +9.6%
Jul 14, 2026 -0.2% None -3.0%S&P +0.8% +6.8%
Apr 24, 2026 -6.2% None -6.0%S&P +0.9% -12.0%
Jan 27, 2026 +0.1% None +4.0%S&P +0.4% +7.8%
Oct 24, 2025 +3.3% None +6.3%S&P +2.0% +10.0%
Jul 25, 2025 -9.8% None -0.3%S&P +0.4% +18.9%
Apr 25, 2025 +0.9% None -2.8%S&P +0.8% +14.0%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

HCA short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 54% of volume sold short2026-08-27: 71% of volume sold short2026-08-28: 56% of volume sold short2026-08-31: 66% of volume sold short2026-09-01: 59% of volume sold short2026-09-02: 62% of volume sold short2026-09-03: 65% of volume sold short2026-09-04: 76% of volume sold short2026-09-08: 79% of volume sold short2026-09-09: 79% of volume sold short2026-09-10: 74% of volume sold short2026-09-11: 76% of volume sold short2026-09-14: 72% of volume sold short2026-09-15: 61% of volume sold short2026-09-16: 67% of volume sold short2026-09-17: 72% of volume sold short2026-09-18: 72% of volume sold short2026-09-21: 52% of volume sold short2026-09-22: 47% of volume sold short2026-09-23: 56% of volume sold short2026-09-24: 67% of volume sold short2026-09-25: 57% of volume sold short2026-09-28: 50% of volume sold short2026-09-29: 45% of volume sold short2026-09-30: 53% of volume sold short2026-10-01: 67% of volume sold short2026-10-02: 70% of volume sold short2026-10-05: 62% of volume sold short2026-10-06: 69% of volume sold short2026-10-07: 61% of volume sold short2026-10-08: 62% of volume sold short2026-10-09: 65% of volume sold short2026-10-12: 50% of volume sold short2026-10-13: 49% of volume sold short2026-10-14: 58% of volume sold short2026-10-15: 46% of volume sold short2026-10-16: 53% of volume sold short2026-10-19: 67% of volume sold short2026-10-20: 74% of volume sold short2026-10-21: 69% of volume sold short2026-10-22: 50% of volume sold short2026-10-23: 77% of volume sold short2026-10-26: 67% of volume sold short2026-10-27: 60% of volume sold short2026-10-28: 38% of volume sold short2026-10-29: 52% of volume sold short2026-10-30: 64% of volume sold short2026-11-02: 54% of volume sold short2026-11-03: 66% of volume sold short2026-11-04: 42% of volume sold short2026-11-05: 58% of volume sold short2026-11-06: 47% of volume sold short2026-11-09: 51% of volume sold short2026-11-10: 31% of volume sold short2026-11-11: 48% of volume sold short2026-11-12: 58% of volume sold short2026-11-13: 50% of volume sold short2026-11-16: 54% of volume sold short2026-11-17: 46% of volume sold short2026-11-18: 53% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 53%20-day average: 53%Prior 2 months: 63%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded HCA

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 -1.8%

Insiders at HCA Healthcare

InsiderBoughtSoldLast filingPast buys beat S&PScore
Samuel N. HazenCEO — $21.5M Feb 12, 2026 — —
Jon M. FosterCOO — $15.9M Nov 6, 2026 — —
Jennifer BerresSvp & Chief Human Res. Officer — $4.1M Feb 12, 2026 — —
Michael R. McAleveyGeneral Counsel — $2.7M Aug 28, 2026 — —
Christopher F. WyattSvp & Controller — $2.0M Feb 12, 2026 — —
Erica RossittoSvp & Chief Nurse Executive — $1.8M Nov 10, 2026 — —
Michael S. CuffeEvp And Chief Clinical Officer — $747K Feb 12, 2026 — —
Michael J. SchlosserEvp And Chief Clinical Officer — $594K Nov 17, 2026 — —
Patricia F. Elcan10% Owner — — Nov 6, 2026 — —
Thomas F. Frist IIIDirector — — Nov 6, 2026 — —
Mike A. MarksCFO — — Nov 3, 2026 — —
William R. FristDirector — — Apr 30, 2026 — —
John ChidseyDirector — — Apr 30, 2026 — —
Nancy Ann DeparleDirector — — Apr 30, 2026 — —
Hugh F. JohnstonDirector — — Apr 30, 2026 — —
Michael W. MichelsonDirector — — Apr 30, 2026 — —
Wayne Joseph RileyDirector — — Apr 30, 2026 — —
Andrea B. SmithDirector — — Apr 30, 2026 — —
II Holding Frisco10% Owner — — Feb 10, 2026 — —
II Holding Hercules10% Owner — — Feb 10, 2026 — —
Thomas F. Frist Jr.10% Owner — — Feb 10, 2026 — —

Board links: companies that share insiders with HCA

Directors and executives who filed Form 4s for HCA and another company in the last 12 months.

See the map →
  • DISWalt Disney Hugh F. Johnston Director here · CFO at DIS · latest filing Apr 30, 2026
  • NCLHNorwegian Cruise Line John Chidsey Director here · CEO, President at NCLH · latest filing May 26, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

HCA stock: common questions

Are HCA Healthcare insiders buying HCA stock?

No. No HCA Healthcare insider reported an open-market purchase of HCA in the past 12 months.

Are HCA Healthcare insiders selling HCA stock?

8 insiders reported sales worth $47.5M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is HCA's P/E ratio?

HCA trades at about 16.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is HCA's 52-week range?

Over the past year HCA has traded between $359.93 and $542.23. It last closed at $461.58 on Nov 19, 2026.